EUVIMEDEUVIMED entdecken
Crossref

A new face in the treatment of Philadelphia chromosome‐positive acute lymphoblastic leukaemia

Takeshi Kondo iD

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19845 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Takeshi Kondo. Beteiligte Einrichtung: Blood Disorders Center, Aiiku Hospital, Sapporo, Japan. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Protein Kinase Inhibitors, Philadelphia Chromosome. Die Arbeit nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prognosis for patients with relapsed/refractory or measurable (minimal) residual disease‐positive Philadelphia chromosome (Ph)‐positive acute lymphoblastic leukaemia (ALL) is poor. Currently, ponatinib is the only approved tyrosine kinase inhibitor (TKI) that is effective for Ph‐positive ALL with the T315I mutation. Although the report by Liu et al. is a retrospective observational study, it offers prospects for the efficacy of chemotherapy combined with the novel third‐generation TKI, olverembatinib, in these conditions, which may be validated in future prospective clinical trials. Commentary on: Liu et al. Efficacy and safety of olverembatinib in adult BCR::ABL1‐positive ALL with T315I mutation or relapsed/refractory disease. Br J Haematol 2024; 205: 2228‐2233 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor Cell Lymphoblastic Leukemia-LymphomaProtein Kinase InhibitorsPhiladelphia ChromosomeHumansPyridazinesImidazolesFusion Proteins, bcr-ablMutation

Stichwörter der Autor:innen

Philadelphia chromosome (Ph)‐positiveacute lymphoblastic leukemiaminimal residual disease‐positive

Substanzen

Protein Kinase InhibitorsPyridazinesponatinibImidazolesFusion Proteins, bcr-abl

Autor:innen und Institutionen

  • Blood Disorders Center, Aiiku Hospital, Sapporo, Japan.

ORCID-Profile: Takeshi Kondo

Zitieren

APA

Kondo, T. (2024). A new face in the treatment of Philadelphia chromosome‐positive acute lymphoblastic leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.19845

Vancouver

Kondo T. A new face in the treatment of Philadelphia chromosome‐positive acute lymphoblastic leukaemia. British Journal of Haematology. 2024. doi:10.1111/bjh.19845

BibTeX
@article{Kondo2024,
  author = {Kondo, Takeshi},
  title = {A new face in the treatment of Philadelphia chromosome‐positive acute lymphoblastic leukaemia},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19845}
}
Kostenlos starten →